At Davos, e& and IBM announced a collaboration to implement agentic AI, powered by watsonx, to transform governance, risk, and compliance operations within the enterprise.

The pharmaceutical industry is poised for a paradigm shift from Research & Development (R&D) to Research & Prediction (R&P), with agentic AI expected to deliver the first fully predictive drug development pipeline by 2026.